Enamel matrix derivative (EMD; Emdogain) vs placebo or control
Change in probing pocket depth (PPD) · Patients affected by chronic, aggressive, or early onset periodontitis, with intrabony defects having an intrabony component of at least 3…
Enamel matrix derivative (EMD; Emdogain) may leads to higher change in probing pocket depth (PPD) compared with placebo or control (same surgical or non-surgical intervention… (low certainty).
1 finding from 1 review
- Enamel matrix derivative (Emdogain®) for periodontal tissue regeneration in intrabony defects 2009 · Cochrane All outcomes1 year (time-points 1, 5 and 10 years planned)MD 0.88 [0.44, 1.31]9 studies · 371 participantsLow